Answers are grounded in this paper and cite their sources.
Retrospective cohort analysis shows omentectomy improves survival compared to biopsy in early-stage uterine serous carcinoma, suggesting better long-term prognosis.
Objectives This study aims to compare the effects of different omental assessment methods (omentectomy and omental biopsy) on the long-term prognosis of apparent early-stage uterine serous cancer (USC). Methods A total of 255 women with clinical early-stage USC were included. They were divided into the omentectomy group and the omental biopsy group. The Kaplan-Meier method and the log-rank test were employed to estimate and compare overall survival and disease-free survival between groups. The Cox proportional hazards regression model was used to adjust for potential confounding factors. Results When compared with undergoing omentectomy, women with apparent early-stage USC who underwent omental biopsy had a deteriorated 5-year OS (HR: 1.76, 95% CI: 1.07-3.52, P =0.009) and 5-year DFS (HR: 1.72, 95% CI: 1.15-2.86, P =0.012). After adjusting for confounding factors, omental biopsy was independently associated with worsening long-term prognosis in apparent early-stage USC (For DFS, aHR=1.78, 95% CI: 1.13-3.20, P =0.025; For OS, aHR=1.68, 95% CI: 1.11-2.75, P =0.041). Conclusions For apparent early-stage USC, in terms of long-term survival outcomes, omentectomy is superior to omental biopsy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: